Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.

Back

HFA Premium Access

Use of SGLT2 inhibitors in real life: predicting left ventricular reverse remodelling.

Session: ePosters in interventional cardiology and pharmacology 2

Topic: Antidiabetic Pharmacotherapy

Speaker: Doctor V. De Simone (Legnago, IT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Vincenzo De Simone

Mater Salutis Hospital, Legnago (Italy)

2 presentations

0 follower

6 more presentations in this session

Challenging the norm: the use of sublingual nitroglycerin in patients with severe aortic stenosis undergoing cardiac CT

Speaker: Doctor A. Silva (Coimbra, PT)

Age differences in prescribing guideline-directed medical treatment in heart failure with mildly reduced and reduced ejection fraction

Speaker: Doctor V. Lopes (Coimbra, PT)

Adherence to the guideline-directed medical therapy in chronic heart failure: insight from a University Hospital

Speaker: Doctor M. Assamti (Oujda, MA)

Prescribing SGLT2 inhibitors in acute heart failure: considerations for dysglycemia status, heart failure phenotype, and kidney function

Speaker: Doctor A. Amanova (Aktobe, KZ)

Real world registry of use of SGLT2i in patients with HFrEF followed in a non-tertiary hospital.

Speaker: Mr V. Martinez Mateo (Alcazar de San Juan, ES)

Access the full session

ePosters in interventional cardiology and pharmacology 2

Speakers: Doctor V. De Simone, Doctor A. Silva, Doctor V. Lopes, Doctor M. Assamti, Doctor A. Amanova...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources